38
Participants
Start Date
April 16, 2007
Primary Completion Date
May 19, 2008
Study Completion Date
December 25, 2009
LBH589
Christiana Care, Newark
Wake Forest, Winston-Salem
Duke, Durham
Emory University, Atlanta
Moffitt Cancer Center, Tampa
Sarah Canon Research Center, Nashville
Vanderbilt, Nashville
Metrohealth, Cleveland
Indiana University, Indianapolis
University of Michigan, Ann Arbor
Rush University, Chicago
University of Chicago, Chicago
Washington University, St Louis
CTRC, San Antonio
Rocky Mountain Cancer Center, Denver
Mayo Clinic, Scottsdale
City of Hope, Duarte
UCSF, San Francisco
Stanford, Stanford
Aptium Oncology, Berkeley
University of Iowa, Iowa City
Dana Farber, Boston
Hackensack University, Hackensack
University of Texas Southwestern, Dallas
Novartis investigative Site, Berlin
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Kiel
Novartis Investigative Site, Starnberg
Novartis Investigative Site, Würzburg
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY